Flecainide acetate for resistant arrhythmias in the young: Efficacy and pharmacokinetics

Ward, 1986, Use of flecainide acetate for refractory functional tachycardias in children with the WolffParkinson-White syndrome, Am J Cardiol, 57, 787, 10.1016/0002-9149(86)90614-4 Wren, 1987, The response of paediatric arrhythmias to intravenous and oral flecainide, Br Heart J, 57, 171, 10.1136/hrt.57.2.171 Zeigler, 1988, Flecainide for supraventricular tachycardia in children, Am J Cardiol, 62, 41D, 10.1016/0002-9149(88)90505-X Holmes, 1985, Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy, Drugs, 29, 1, 10.2165/00003495-198529010-00001 1983, Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial, Circulation, 67, 1117, 10.1161/01.CIR.67.5.1117 Neuss, 1983, Effects of flecainide on electrophysiologic properties of accessory pathways in the Wolff-Parkinson-White syndrome, Eur Heart J, 4, 347, 10.1093/oxfordjournals.eurheartj.a061472 Garson, 1986, Dosing the newer antiarrhythmic drugs in children: considerations in pediatric pharmacology (editorial), Am J Cardiol, 57, 1405, 10.1016/0002-9149(86)90227-4 Chang, 1984, Determination of flecainide in human plasma by high performance liquid chromatography with fluorescence detection, J Liq Chromatogr, 7, 167, 10.1080/01483918408073957 Conard, 1984, Metabolism of flecainide, Am J Cardiol, 53, 41B, 10.1016/0002-9149(84)90501-0 Shumaker, 1986, PKCALC: A basic interactive computer program for statistical and pharmacokinetic analysis of data, Drug Metab Rev, 17, 331, 10.3109/03602538608998295 Kim, 1986, Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate, Am J Cardiol, 58, 80, 10.1016/0002-9149(86)90245-6 Gillette, 1985, Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathy, JAMA, 253, 391, 10.1001/jama.1985.03350270089028 Josephson, 1984, Effects of flecainide on ventricular function: clinical and experimental correlations, Am J Cardiol, 53, 95B, 10.1016/0002-9149(84)90510-1 Anderson, 1981, Oral flecainide acetate for the treatment of ventricular arrhythmias, N Engl J Med, 305, 473, 10.1056/NEJM198108273050901 Platia, 1985, Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia, Am J Cardiol, 55, 956, 10.1016/0002-9149(85)90726-X Estes, 1984, Elect rophysiologic properties of flecainide acetate, Am J Cardiol, 53, 9B, 10.1016/0002-9149(84)90498-3 Garson, 1987, Incessant ventricular tachycardia in infants: myocardial harmartomas and surgical cure, J Am Coll Cardiol, 10, 619, 10.1016/S0735-1097(87)80205-X McQuinn, 1984, Biotransformation and elimination of 14C-flecainide acetate in humans, Drug Metab Dispos, 12, 414